Search research articles
Contact Us
Filters
Showing results (281-290 of 404) with videos related to
Page
of 41
Sort By:
Advances in Biochemical Psychopharmacology
|
January 1, 1995
Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry
R H Belmaker, Y Bersudsky, J Benjamin, et al.
Bipolar Disorders
|
April 14, 2007
Specificity of mood stabilizer action on neuronal growth cones
Galit Shaltiel, Emma C Dalton, Robert H Belmaker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 1, 1994
Behavioral evidence for the existence of two pools of cellular inositol
Y Bersudsky, Z Kaplan, Y Shapiro, et al.
Psychoneuroendocrinology
|
January 1, 1981
Lack of effect of beta-2 adrenergic stimulation on human prolactin
J Bannet, B Lerer, R P Ebstein, et al.
Biological Psychiatry
|
May 1, 1985
Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives
B Shapira, G Oppenheim, J Zohar, et al.
The American Journal of Psychiatry
|
July 1, 1995
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
J Benjamin, J Levine, M Fux, et al.
Psychopharmacology
|
January 1, 1984
Ineffectiveness of vasopressin in the treatment of memory impairment in chronic schizophrenia
D Stein, J Bannet, I Averbuch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Inositol treatment of autism
J Levine, A Aviram, A Holan, et al.
Biological Psychiatry
|
October 20, 1998
Inositol levels are decreased in postmortem brain of schizophrenic patients
H Shimon, Y Sobolev, M Davidson, et al.
The American Journal of Psychiatry
|
August 1, 1997
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder
H Shimon, G Agam, R H Belmaker, et al.
Page
of 41
Search research articles
Search
Showing results (281-290 of 404) with videos related to
Sort By:
Page
of 41
Advances in Biochemical Psychopharmacology
|
January 1, 1995
Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry
R H Belmaker, Y Bersudsky, J Benjamin, et al.
Bipolar Disorders
|
April 14, 2007
Specificity of mood stabilizer action on neuronal growth cones
Galit Shaltiel, Emma C Dalton, Robert H Belmaker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 1, 1994
Behavioral evidence for the existence of two pools of cellular inositol
Y Bersudsky, Z Kaplan, Y Shapiro, et al.
Psychoneuroendocrinology
|
January 1, 1981
Lack of effect of beta-2 adrenergic stimulation on human prolactin
J Bannet, B Lerer, R P Ebstein, et al.
Biological Psychiatry
|
May 1, 1985
Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives
B Shapira, G Oppenheim, J Zohar, et al.
The American Journal of Psychiatry
|
July 1, 1995
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
J Benjamin, J Levine, M Fux, et al.
Psychopharmacology
|
January 1, 1984
Ineffectiveness of vasopressin in the treatment of memory impairment in chronic schizophrenia
D Stein, J Bannet, I Averbuch, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Inositol treatment of autism
J Levine, A Aviram, A Holan, et al.
Biological Psychiatry
|
October 20, 1998
Inositol levels are decreased in postmortem brain of schizophrenic patients
H Shimon, Y Sobolev, M Davidson, et al.
The American Journal of Psychiatry
|
August 1, 1997
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder
H Shimon, G Agam, R H Belmaker, et al.
Page
of 41